Karenitecin in Treating Patients With Recurrent Malignant Glioma

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of karenitecin in treating patients who have recurrent malignant glioma.

Timeline

Start

2002-01

Primary completion

—

Completion

—

Drugs

Indications